Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Intra-Cellular Therapies, Inc. | Executive Vice President & CFO | Restricted Stock Units | 35K | $2.4M | $68.49 | Aug 12, 2024 | Direct |
Viatris Inc | Chief Financial Officer | Restricted Stock Units | 77.8K | $862K | $11.08 | Mar 4, 2023 | Direct |
Viatris Inc | Chief Financial Officer | Common Stock | 73.9K | $850K | $11.50 | Mar 4, 2023 | Direct |
Viatris Inc | Chief Financial Officer | Dividend Equivalent Units | 2.8K | $31K | $11.08 | Mar 4, 2023 | Direct |
Intra-Cellular Therapies, Inc. | Executive Vice President & CFO | Stock Option (right to buy) | 17.3K | Aug 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ITCI | Intra-Cellular Therapies, Inc. | Aug 12, 2024 | 2 | $0 | 4 | Aug 14, 2024 | Executive Vice President & CFO |
ITCI | Intra-Cellular Therapies, Inc. | Aug 12, 2024 | 0 | $0 | 3 | Aug 14, 2024 | Executive Vice President & CFO |
VTRS | Viatris Inc | Mar 2, 2023 | 13 | -$331K | 4 | Mar 6, 2023 | Chief Financial Officer |
VTRS | Viatris Inc | Feb 27, 2023 | 6 | -$112K | 4 | Mar 1, 2023 | Chief Financial Officer |
VTRS | Viatris Inc | Mar 21, 2022 | 2 | $0 | 4 | Mar 23, 2022 | Chief Financial Officer |
VTRS | Viatris Inc | Mar 2, 2022 | 7 | -$122K | 4 | Mar 4, 2022 | Chief Financial Officer |
VTRS | Viatris Inc | Dec 21, 2021 | 2 | $0 | 4 | Dec 23, 2021 | Chief Financial Officer |
VTRS | Viatris Inc | Sep 22, 2021 | 2 | $0 | 4 | Sep 24, 2021 | Chief Financial Officer |
VTRS | Viatris Inc | Jun 21, 2021 | 2 | $0 | 4 | Jun 23, 2021 | Chief Financial Officer |